Operational and Technical Achievements Set Stage for Expected Major Growth and Profitability in 2022
Investor Call Scheduled for Wednesday, November 17, 2021 at 4:30 p.m. ET
SOUTH EASTON, MA / ACCESSWIRE / November 17, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food & beverage industries, today reported financial results for the third quarter ended September 30, 2021, provided a business update, and offered guidance for an expected strong 2022.
Financial Highlights: Q3 2021 vs. Q3 2020 (rounded to nearest hundred except EPS)